Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 2
1995 3
1996 2
1997 1
1998 2
1999 1
2000 4
2001 2
2002 5
2003 2
2004 6
2005 8
2006 2
2007 1
2008 2
2009 2
2010 3
2011 5
2012 3
2013 9
2014 9
2015 12
2016 7
2017 6
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
Image Informatics Strategies for Deciphering Neuronal Network Connectivity.
Detrez JR, Verstraelen P, Gebuis T, Verschuuren M, Kuijlaars J, Langlois X, Nuydens R, Timmermans JP, De Vos WH. Detrez JR, et al. Among authors: langlois x. Adv Anat Embryol Cell Biol. 2016;219:123-48. doi: 10.1007/978-3-319-28549-8_5. Adv Anat Embryol Cell Biol. 2016. PMID: 27207365 Free article. Review.
Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer's Disease.
Rombouts FJ, Andrés JI, Ariza M, Alonso JM, Austin N, Bottelbergs A, Chen L, Chupakhin V, Cleiren E, Fierens K, Fontana A, Langlois X, Leenaerts JE, Mariën J, Martínez Lamenca C, Salter R, Schmidt ME, Te Riele P, Wintmolders C, Trabanco AA, Zhang W, Macdonald G, Moechars D. Rombouts FJ, et al. Among authors: langlois x. J Med Chem. 2017 Feb 23;60(4):1272-1291. doi: 10.1021/acs.jmedchem.6b01173. Epub 2017 Feb 10. J Med Chem. 2017. PMID: 28106992
Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging.
Declercq L, Rombouts F, Koole M, Fierens K, Mariën J, Langlois X, Andrés JI, Schmidt M, Macdonald G, Moechars D, Vanduffel W, Tousseyn T, Vandenberghe R, Van Laere K, Verbruggen A, Bormans G. Declercq L, et al. Among authors: langlois x. J Nucl Med. 2017 Jun;58(6):975-981. doi: 10.2967/jnumed.116.185199. Epub 2017 Feb 23. J Nucl Med. 2017. PMID: 28232614 Free article.
Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia.
Conde-Ceide S, Martínez-Viturro CM, Alcázar J, Garcia-Barrantes PM, Lavreysen H, Mackie C, Vinson PN, Rook JM, Bridges TM, Daniels JS, Megens A, Langlois X, Drinkenburg WH, Ahnaou A, Niswender CM, Jones CK, Macdonald GJ, Steckler T, Conn PJ, Stauffer SR, Bartolomé-Nebreda JM, Lindsley CW. Conde-Ceide S, et al. Among authors: langlois x. ACS Med Chem Lett. 2015 May 20;6(6):716-20. doi: 10.1021/acsmedchemlett.5b00181. eCollection 2015 Jun 11. ACS Med Chem Lett. 2015. PMID: 26157544 Free PMC article.
Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target Engagement.
Buijnsters P, De Angelis M, Langlois X, Rombouts FJ, Sanderson W, Tresadern G, Ritchie A, Trabanco AA, VanHoof G, Roosbroeck YV, Andrés JI. Buijnsters P, et al. Among authors: langlois x. ACS Med Chem Lett. 2014 Jul 22;5(9):1049-53. doi: 10.1021/ml500262u. eCollection 2014 Sep 11. ACS Med Chem Lett. 2014. PMID: 25221665 Free PMC article.
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page